Notice of Proposed Sale · 144
Insmed Incorporated
INSMNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- INSMED INC
- Issuer CIK
- 0001104506
- SEC file number
- 000-30739
- Phone
- 9089779900
- Person for whose account securities are to be sold
- Martina Flammer
- Relationships to issuer
- Officer
- Street
- 700 US Highway 202/206
- City
- Bridgewater
- State / country code
- NJ
- Postal code
- 08807
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 12,302 | 1,352,864 | 216,752,451 | 07/06/2026 | NASDAQ | Merrill Lynch |
Broker / market maker — proposed row 1, entry 1
- Name
- Merrill Lynch
- Street
- 1800 K ST NW
- Street (continued)
- Suite 800
- City
- Washington
- State / country code
- DC
- Postal code
- 20006
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/06/2026 | Stock Plan Activity | Issuer | 12,302 | N | 07/06/2026 | n/a |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Martina Flammer | Common | 06/05/2026 | 1,858 | 192,811 |
| Martina Flammer | Common | 06/03/2026 | 2,566 | 262,418 |
| Martina Flammer | Common | 05/14/2026 | 10,479 | 1,231,599 |
| Martina Flammer | Common | 05/13/2026 | 7,854 | 897,137 |
| Martina Flammer | Common | 05/11/2026 | 12,949 | 1,300,105 |
Seller — prior-sale row 1, entry 1
- Name
- Martina Flammer
- Street
- 700 US Highway 202/206
- City
- Bridgewater
- State / country code
- NJ
- Postal code
- 08807
Seller — prior-sale row 2, entry 1
- Name
- Martina Flammer
- Street
- 700 US Highway 202/206
- City
- Bridgewater
- State / country code
- NJ
- Postal code
- 08807
Seller — prior-sale row 3, entry 1
- Name
- Martina Flammer
- Street
- 700 US Highway 202/206
- City
- Bridgewater
- State / country code
- NJ
- Postal code
- 08807
Seller — prior-sale row 4, entry 1
- Name
- Martina Flammer
- Street
- 700 US Highway 202/206
- City
- Bridgewater
- State / country code
- NJ
- Postal code
- 08807
Seller — prior-sale row 5, entry 1
- Name
- Martina Flammer
- Street
- 700 US Highway 202/206
- City
- Bridgewater
- State / country code
- NJ
- Postal code
- 08807
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 07/06/2026
- Signed
- Martina Flammer
- Plan adoption dates
- 02/27/2025
Company context
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines - including two approved therapies to treat chronic, debilitating lung diseases - as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. The Company's research engine is advancing a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue, in the pursuit of future pipeline candidates.
Current securities
Recent company filings
- Results of Operations and Financial ConditionOct 29, 2026
- 10-Q filingOct 29, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureOct 20, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureOct 5, 2026
- 4 filingSep 11, 2026